Raffa Wealth Management’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Other funds holding PCVX
Raffa Wealth Management's PCVX Position: Q3 2026 in Review
Raffa Wealth Management opened a new position in Vaxcyte (PCVX) in Q3 2026: 1 share worth $57. The stake represents ﹤0.01% of the portfolio and ranks #1513 among its holdings.
356 funds tracked by Wall St. Rank hold PCVX as of Q3 2026.
- Raffa Wealth Management held 1 share of Vaxcyte worth $57 as of Q3 2026.
- Vaxcyte was a new Raffa Wealth Management position in Q3 2026.
- Vaxcyte made up ﹤0.01% of Raffa Wealth Management's portfolio in Q3 2026, its #1513 holding.
- 356 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2026.
Based on Raffa Wealth Management's 13F filing for Q3 2026, filed 16 Nov 2026.